Indication
HIV Infections with Multi-Drug Resistant Virus
1 clinical trial
1 product
Clinical trial
A Multicenter, Open-label, Single-arm Trial to Evaluate the Safety, Pharmacokinetics and Antiviral Activity of Fostemsavir in Combination With Optimized Background Therapy (OBT) in HIV-1 Infected Children and Adolescents Who Are Failing Their Current Combination Antiretroviral Therapy (cART) and Have Dual- or Triple-class Antiretroviral (ARV) ResistanceStatus: Recruiting, Estimated PCD: 2025-06-01
Product
Fostemsavir